Evaluation of Xuefu Zhuyu Oral Solution as an Add-on Therapy for Stable Angina: Results from a Randomized Controlled Trial - Top-Institutions - MDSpire

Evaluation of Xuefu Zhuyu Oral Solution as an Add-on Therapy for Stable Angina: Results from a Randomized Controlled Trial

  • By

  • Wencong Cao

  • Shaojun Liao

  • Li Zhou

  • Geng Li

  • Junwen Jiang

  • Weihui Lv

  • Bo Dong

  • Li Liu

  • Jie Zhang

  • Yanchun Wang

  • Wenwei Ouyang

  • Yi Du

  • Zehuai Wen

  • April 29, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Cardiovascular Research

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Clinical Research

  • #3

    Peking Union Medical College Hospital
    Peking Union Medical College Hospital

    Beijing, Beijing

    Key Differentiators

    • Cardiology
    • Traditional Chinese Medicine

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Cardiovascular Research

  • #5

    Fuwai Hospital, Chinese Academy of Medical Sciences
    Fuwai Hospital, Chinese Academy of Medical Sciences

    Beijing, Beijing

    Key Differentiators

    • Cardiology
    • Cardiovascular Medicine
    • Traditional Chinese Medicine

Original Source(s)

Evaluation of Xuefu Zhuyu Oral Solution as an Add-on Therapy for Stable Angina: Results from a Randomized Controlled Trial

  • by Wencong Cao, Shaojun Liao, Li Zhou, Geng Li, Junwen Jiang, Weihui Lv, Bo Dong, Li Liu, Jie Zhang, Yanchun Wang, Wenwei Ouyang, Yi Du, Zehuai Wen

  • April 29, 2026

Related Content

Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study

Antivirals Linked to Lower Hospitalization in Influenza

Matched cohort study in nonhospitalized patients

Limonin Reduces Pyroptosis and Inflammation in Myocardial Ischemia-Reperfusion Mice by Targeting the Caspase-3/GSDME Pathway